Hori and colleagues [1] investigated rewarming strategies in cardiopulmonary bypass (CPB) and their relationship with plasma levels of glial fibrillary acidic protein (GFAP), a serum protein generated by ischemic or necrotic cerebral astrocytes, or both.
The aim of this study was to evaluate the possibility to use platelet gel (PG) as an adjuvant therapy when performing TMA procedure in diabetic patients.
